Black Rock Inc. Syndax Pharmaceuticals Inc Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 7,552,431 shares of SNDX stock, worth $146 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,552,431

Previous 7,015,548 7.65%

Holding current value

$146 Million

Previous $152 Million 18.56%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$19.71 - $24.57 $10.6 Million - $13.2 Million	536,883 Added 7.65%	7,552,431 $180 Million
Q4 2023 Feb 13, 2024	BUY	$11.39 - $21.67 $12.9 Million - $24.6 Million	1,132,912 Added 19.26%	7,015,548 $152 Million
Q3 2023 Nov 13, 2023	BUY	$14.52 - $21.77 $12.9 Million - $19.4 Million	891,652 Added 17.87%	5,882,636 $85.4 Million
Q2 2023 Aug 11, 2023	BUY	$19.35 - $22.31 $1.74 Million - $2.01 Million	90,143 Added 1.84%	4,990,984 $104 Million
Q1 2023 May 12, 2023	BUY	$20.66 - $28.98 $11.3 Million - $15.9 Million	548,809 Added 12.61%	4,900,841 $104 Million

Q4 2022 Feb 13, 2023	BUY	$20.64 - $26.24 $4.38 Million - $5.57 Million	212,415 Added 5.13%	4,352,032 $111 Million
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $6.36 Million - $8.52 Million	343,708 Added 9.05%	4,139,617 $99.5 Million
Q2 2022 Aug 12, 2022	SELL	$13.64 - $19.48 $30,567 - $43,654	-2,241 Reduced 0.06%	3,795,909 $73 Million
Q1 2022 May 12, 2022	BUY	$14.84 - $22.15 $1.61 Million - $2.4 Million	108,256 Added 2.93%	3,798,150 $66 Million
Q4 2021 Feb 10, 2022	BUY	$15.23 - $22.47 $2.49 Million - $3.68 Million	163,596 Added 4.64%	3,689,894 $80.8 Million
Q3 2021 Nov 09, 2021	BUY	$13.87 - $19.8 $88,823 - $126,799	6,404 Added 0.18%	3,526,298 $67.4 Million
Q2 2021 Aug 11, 2021	BUY	$13.42 - $25.18 $47.2 Million - $88.6 Million	3,519,894 New	3,519,894 $60.4 Million

Others Institutions Holding SNDX

# of Institutions

195

Shares Held

90M

Call Options Held

353K

Put Options Held

207K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $1.09B
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account